Amneal – Recall of metformin extended-release (ER)
June 3, 2020 - Amneal announced a voluntary, consumer-level recall of all lots of metformin ER tablets due to the detection of N-nitrosodimethylamine (NDMA) levels in excess of acceptable FDA levels.
Download PDF
